Christine graduated from the University of Nottingham with First Class Honours in Biochemistry and Molecular Medicine in 2023. As part of her studies, she undertook research into vaccines for respiratory and immunodeficiency diseases. Her research investigated how SARS-CoV-2 mediates infection, aided by computational modelling of the SARS-CoV-2 spike protein, to provide insight into the mechanism of action of the COVID-19 RNA vaccines. In her final year dissertation, Christine investigated the protective efficacy and associated immune responses evoked upon vaccinating rhesus macaques with prophylactic cytomegalovirus-vectored SIV vaccines, and explored whether this model could be predictive of corresponding HIV vaccine efficacy in humans.
 
Beyond academia, Christine has extensive experience working in medical communications, where her role involved identifying scientific evidence to substantiate marketing claims.
 
Aside from work, Christine loves to travel and is a keen skier and sailor. She is proud to have been part of the winning crew of the “Overall Performance Cruiser Trophy” in Cowes Week 2023.
 
Christine joined Kilburn & Strode in 2024 as a Trainee Patent Attorney in the Life Sciences and Chemistry group and is currently training to become a Chartered UK and European Patent Attorney.

Qualifications

BSc (Hons) Biochemistry and Molecular Medicine (University of Nottingham)


Memberships

Chartered Institute of Patent Attorneys (CIPA) – student member

The Institute of Professional Representatives before the European Patent Office (EPI) – student member